Create a free MedEsthetics account to continue reading

Agency Skin Launches Personalized Prescription Treatment with Patent-Pending Peptides

Agency Skincare

Agency Skin, a personalized prescription skincare brand, launched a new line of formulas, including a patent-pending Skin Smoothing Booster featuring an exclusive seven-peptide blend, on August 25. 

Developed by its board-certified dermatologists and scientists, Agency Skin's treatments combine advanced, science-backed ingredients including tretinoin, vitamin C, estriol, rapamycin, hydroquinone, and resveratrol to address the interconnected biological processes associated with visible skin aging. 

Related: Allergan Aesthetics Launches Program to Meet Growing Demand for Personalized Aesthetic Solutions

Every patient's prescription formulas and regimen are customized by a licensed medical provider based on their individual needs, goals, medical history, and response to treatment over time.

"Driving real results starts with understanding the skin's underlying biology," said Whitney Tolpinrud, MD, FAAD, Board-Certified Dermatologist and Medical Director at Agency Skin. "Two people may have similar concerns about fine lines, firmness, pigmentation, or texture and still need very different treatments. We can personalize not only the prescription actives we prescribe, but their combinations and strengths, and continue to adjust a patient's treatment as their needs change."

Agency Skin's New Patent-Pending Prescription Treatments

Agency Skin's new prescription lineup addresses multiple signs of visible aging through treatments a licensed medical provider can calibrate with precision, personalizing not just which ingredients to prescribe, but their combinations and strengths for each patient.

Agency Skin's new provider-managed, prescription skincare model reflects an aesthetic shift from aone-time procedure/product mentality to ongoing management of skin health and skin longevity as a medical, personalized, longitudinal treatment strategy

The Science Behind Agency Skin's Approach to Longevity

Agency Skin's new treatments are developed around five interconnected biological pathways associated with visible skin aging: protein degradation, inflammation, cellular repair, oxidative stress, and DNA damage. Each formula is specifically designed around a primary pathway, with secondary support across the others, reflecting the interconnected biology of skin aging.

"Skin aging is extraordinarily complex. There isn't one pathway, one ingredient, or one treatment that determines how we age or how we treat it," said Felipe Jimenez, PhD, Head of Scientific Innovation at Agency Skin. "We developed these formulations to address multiple biological processes associated with visible aging, using ingredients that work in complementary ways across a patient's regimen. Personalization allows us to determine not simply which ingredients to use, but how to combine them and at what strengths for an individual patient."

Personalized prescription treatments start at $110 for a 60-day supply and are available by subscription following a medical consultation. New patients receive 50% off their first 60-day supply.

Agency Skin's non-Rx products start at $40 and can be purchased individually or by subscription.

All products are backed by a 120-day money-back guarantee (restrictions apply). Beginning today, all new treatments and products are available at AgencySkin.com.

More in Treatments